No, lack of transparency forward guidance on revenue streams, no profit taking, lol, systematically being shorted due to the unknowns, e.g. assay results outstanding, resource upgrades, lom extention update, balance sheet for Q2, difficulty bringing on BP33, cost of developing, but I believe this year Gareth will be able to successfully address these.
CXO - Chart Thread, page-7409
Add CXO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $262.5M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 12.0¢ | $2.845M | 21.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 89 | 8806062 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 1408418 | 34 |
View Market Depth
| Last trade - 15.43pm 08/10/2024 (20 minute delay) ? |
| CXO (ASX) Chart |